Reducing inflammation without lowering cholesterol cuts risk of cardiovascular events

Reducing inflammation without lowering cholesterol cuts risk of cardiovascular events

Inflammatory hypothesis confirmed: Landmark randomized clinical trial of high-risk patients finds that a drug targeting inflammation reduced risk of major adverse cardiovascular events. Investigators from Brigham and Women's Hospital today announced results of a...

read more
Reducing inflammation without lowering cholesterol cuts risk of cardiovascular events

Stroke patient improvement with a brain-computer interface

University of Adelaide researchers have shown that it is possible for stroke patients to improve motor function using special training involving connecting brain signals with a computer. In a "proof-of-principle" study published in the journal Royal Society Open...

read more
Reducing inflammation without lowering cholesterol cuts risk of cardiovascular events

How low should LDL cholesterol go?

New analysis shows that in a high-risk population, achieving ultra-low LDL cholesterol levels, down to <10 mg/dL, safely results in additional lowering of risk of cardiovascular events. A newer class of cholesterol lowering drugs known as PCSK9 inhibitors has...

read more

Stroke Action Plan for Europe